278 related articles for article (PubMed ID: 31201897)
1. A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.
Men K; Geng H; Zhong H; Fan Y; Lin A; Xiao Y
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):440-447. PubMed ID: 31201897
[TBL] [Abstract][Full Text] [Related]
2. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
3. Metabolic imaging biomarkers of postradiotherapy xerostomia.
Cannon B; Schwartz DL; Dong L
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1609-16. PubMed ID: 22658215
[TBL] [Abstract][Full Text] [Related]
4. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
[TBL] [Abstract][Full Text] [Related]
6. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
8. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck.
van Dieren EB; Nowak PJ; Wijers OB; van Sörnsen de Koste JR; van der Est H; Binnekamp DP; Heijmen BJ; Levendag PC
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1299-309. PubMed ID: 10889384
[TBL] [Abstract][Full Text] [Related]
9. The Needs and Benefits of Continuous Model Updates on the Accuracy of RT-Induced Toxicity Prediction Models Within a Learning Health System.
Nakatsugawa M; Cheng Z; Kiess A; Choflet A; Bowers M; Utsunomiya K; Sugiyama S; Wong J; Quon H; McNutt T
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):460-467. PubMed ID: 30300689
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Chera BS; Fried D; Price A; Amdur RJ; Mendenhall W; Lu C; Das S; Sheets N; Marks L; Mavroidis P
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1022-1027. PubMed ID: 28721884
[TBL] [Abstract][Full Text] [Related]
11. Early Changes in Serial CBCT-Measured Parotid Gland Biomarkers Predict Chronic Xerostomia After Head and Neck Radiation Therapy.
Rosen BS; Hawkins PG; Polan DF; Balter JM; Brock KK; Kamp JD; Lockhart CM; Eisbruch A; Mierzwa ML; Ten Haken RK; El Naqa I
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1319-1329. PubMed ID: 30003997
[TBL] [Abstract][Full Text] [Related]
12. Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Gouw ZAR; La Fontaine MD; Vogel WV; van de Kamer JB; Sonke JJ; Al-Mamgani A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):960-968. PubMed ID: 32361007
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
14. Relationship between patient and physician-rated xerostomia and dose distribution to the oral cavity and salivary glands for head and neck cancer patients after radiotherapy.
Kaae JK; Johnsen L; Hansen CR; Kristensen MH; Brink C; Eriksen JG
Acta Oncol; 2019 Oct; 58(10):1366-1372. PubMed ID: 31241381
[No Abstract] [Full Text] [Related]
15. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
[TBL] [Abstract][Full Text] [Related]
16. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
18. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia?
You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE
Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607
[TBL] [Abstract][Full Text] [Related]
19. Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT.
Nardone V; Tini P; Nioche C; Mazzei MA; Carfagno T; Battaglia G; Pastina P; Grassi R; Sebaste L; Pirtoli L
Radiol Med; 2018 Jun; 123(6):415-423. PubMed ID: 29368244
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
